Patrick G. Pilié - Concepedia

Author

Patrick G. Pilié

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Chad D. Huff, Gregg Newman, P.G. Pilie, P.G. Pilié, Patrick G Pilie, Patrick G Pilié, Patrick G. Pilie, Patrick G. Pilié, Patrick Glen Pilie, Patrick Glen Pilié

361

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Duke Medical Center Cancer Genetics (United States)The University of Texas Health Science Center at Houston Duke University Hospital

About

Patrick G. Pilié is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	341
2	Immunology	3	3	180
3	Cell Biology	2	2	49
4	Engineering	1	1	22
5	Health Sciences	1	1	16

Patrick G. Pilié

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer Chad Tang, Alexander D. Sherry, Cara Haymaker, JAMA Oncology	2023	171
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma Xian-De Liu, Wen Kong, Christine B. Peterson, Nature Communications	2020	169
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma Pavlos Msaouel, Gabriel G. Malouf, Xiaoping Su, Cancer Cell UrologyGenitourinary CancerKidney ResearchRenal Medullary CarcinomaRenal Pathology	2020	135
ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer Zhe Tang, Patrick G. Pilié, Chuandong Geng, Clinical Cancer Research	2021	134
Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016 Ahmed O. Elmehrath, Ahmed Afifi, Muneer J. Al‐Husseini, JAMA Network Open	2021	107
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial Eric Jonasch, Ian E. McCutcheon, Dan S. Gombos, The Lancet Oncology MedicineClinical DiseaseRheumatoid ArthritisVon Hippel-lindau Disease	2018	96
Germline genetic variants in men with prostate cancer and one or more additional cancers Patrick G. Pilié, Anna Johnson, Kristen Hanson, Cancer	2017	60
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer Cheng Wu, Shan Peng, Patrick G. Pilié, Molecular Cancer Therapeutics	2021	55
CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis Shauna N. Vasilatos, Gloria Broadwater, William T. Barry, Cancer Epidemiology Biomarkers & Prevention	2009	51
Morphologically Normal-Appearing Mammary Epithelial Cells Obtained from High-Risk Women Exhibit Methylation Silencing of <i>INK4a/ARF</i> Gregory R. Bean, Andrew D. Bryson, Patrick G. Pilié, Clinical Cancer Research	2007	47

Page 1